| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.536 | 48.927 | 47.553 | 43.364 | 47.724 | 89.864 | 109.771 | 89.451 | 122.219 | 66.463 |
| Total Income - EUR | 47.536 | 48.927 | 47.553 | 43.364 | 47.724 | 89.864 | 109.780 | 89.451 | 122.219 | 66.463 |
| Total Expenses - EUR | 42.896 | 46.727 | 46.136 | 40.919 | 43.157 | 83.974 | 111.557 | 88.949 | 119.663 | 67.581 |
| Gross Profit/Loss - EUR | 4.640 | 2.200 | 1.417 | 2.446 | 4.567 | 5.891 | -1.777 | 503 | 2.555 | -1.117 |
| Net Profit/Loss - EUR | 3.214 | 1.711 | 941 | 2.012 | 4.090 | 5.041 | -2.875 | -392 | 1.328 | -1.117 |
| Employees | 4 | 4 | 4 | 3 | 1 | 4 | 4 | 3 | 3 | 2 |
Check the financial reports for the company - Med & Vas Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 153 | 151 | 149 | 341 | 335 | 2.318 | 3.778 | 7.519 | 7.497 | 7.455 |
| Current Assets | 10.083 | 9.909 | 9.230 | 7.607 | 8.569 | 11.707 | 9.441 | 6.971 | 5.946 | 10.269 |
| Inventories | 6.890 | 9.577 | 7.246 | 6.435 | 985 | 982 | 399 | 1.588 | 320 | 2.512 |
| Receivables | 21 | 18 | 17 | 761 | 1.586 | 796 | 3.399 | 3.461 | 1.366 | 3.314 |
| Cash | 3.173 | 314 | 1.967 | 411 | 5.998 | 9.930 | 5.642 | 1.922 | 4.261 | 4.442 |
| Shareholders Funds | 6.432 | 1.774 | 2.685 | 4.648 | 4.150 | 9.112 | 6.035 | 5.662 | 6.973 | 5.816 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.804 | 8.286 | 6.694 | 3.301 | 4.754 | 4.914 | 7.184 | 8.828 | 6.470 | 11.907 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9531 - 9531" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Med & Vas Srl